| 2 | Engineering Bioinspired Nanomedicines to Mitigate the Resistance to Cancer Immunotherapy显示文摘CONSPECTUS:The current era has witnessed the success of immunotherapy,in particular,immune checkpoint blockade(ICB)therapy,at an unprecedented pace.However,immunotherapy often fails to unleash the antitumor immune response because of the paucity of appropriate therapeutic targets in the complex tumor microenvironment(TME)and the occurrence of intrinsic and adaptive immune resistance of tumor cells.In recent years,we have rationally engineered a set of bioinspired stimuli-activatable nanotherapeutics to circumvent cancer immune resistance and potentiate cancer immunotherapy. | Jiayi Ye Bo Hou Madiha Saeed Zhiai Xu Haijun Yu | 2022 | Accounts of Materials Research2022，3，7： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员